Iodine Without the Backlash
57:37–59:05 · 88s
Addressing iodine’s controversy, Amie explains why dosing must start low and slow to avoid hyper-like symptoms, preferring gentler nascent iodine and patient-led titration.
57:37–59:05 · 88s
Addressing iodine’s controversy, Amie explains why dosing must start low and slow to avoid hyper-like symptoms, preferring gentler nascent iodine and patient-led titration.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.